Literature DB >> 2866465

Ketamine acts as a non-competitive N-methyl-D-aspartate antagonist on frog spinal cord in vitro.

D Martin, D Lodge.   

Abstract

The effects of the dissociative anaesthetic, ketamine, the divalent cation, magnesium and the organic antagonist, 2-amino-5-phosphonovalerate (APV), were examined on responses of motoneurones to excitatory amino acids in the hemisected spinal cord of the frog in vitro. The amino acids, N-methyl-D-aspartate (NMDA), kainate and quisqualate, produced dose-dependent depolarizations. Ketamine, magnesium and APV depressed responses to NMDA but had no effect on those to quisqualate and kainate. Magnesium and APV produced Schild plot slopes that were not different from unity, whereas ketamine had a slope significantly less than unity, indicative of a non-competitive action. Experiments in which combinations of drugs were tested indicated that these substances act by three distinct mechanisms to cause antagonism of the actions of NMDA.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2866465     DOI: 10.1016/0028-3908(85)90128-5

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  28 in total

1.  The role of N-methylaspartate receptors in mediating responses of rat and cat spinal neurones to defined sensory stimuli.

Authors:  P M Headley; C G Parsons; D C West
Journal:  J Physiol       Date:  1987-04       Impact factor: 5.182

2.  Effects of MK-801, a non-competitive NMDA antagonist, on linguopharyngeal events in rats.

Authors:  L A Marco; R S Joshi; R B Chronister
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Pharmacological characterization of the N-methyl-D-aspartate (NMDA) receptor-channel in rodent and dog brain and rat spinal cord using [3H]MK-801 binding.

Authors:  N A Sharif; J L Nunes; R L Whiting
Journal:  Neurochem Res       Date:  1991-05       Impact factor: 3.996

Review 4.  GABAA receptors, anesthetics and anticonvulsants in brain development.

Authors:  Oliver Henschel; Keith E Gipson; Angelique Bordey
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-04       Impact factor: 4.388

5.  Lack of persistent effects of ketamine in rodent models of depression.

Authors:  Piotr Popik; Tomasz Kos; Magdalena Sowa-Kućma; Gabriel Nowak
Journal:  Psychopharmacology (Berl)       Date:  2008-05-07       Impact factor: 4.530

6.  The Epidural and Intrathecal Administration of Ketamine.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

7.  Quinoxalinediones selectively block quisqualate and kainate receptors and synaptic events in rat neocortex and hippocampus and frog spinal cord in vitro.

Authors:  E J Fletcher; D Martin; J A Aram; D Lodge; T Honoré
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

8.  Effects of striatal ΔFosB overexpression and ketamine on social defeat stress-induced anhedonia in mice.

Authors:  Rachel J Donahue; John W Muschamp; Scott J Russo; Eric J Nestler; William A Carlezon
Journal:  Biol Psychiatry       Date:  2014-01-08       Impact factor: 13.382

9.  Proceedings of the British Pharmacological Society. 17th-19th December 1986. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

10.  A comparison of excitatory amino acid antagonists acting at primary afferent C fibres and motoneurones of the isolated spinal cord of the rat.

Authors:  R H Evans; S J Evans; P C Pook; D C Sunter
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.